MORGAN STANLEY

Major Shareholding Notification • Jan 12, 2026

National Storage Mechanism | Additional information

RNS Number : 5160O

Morgan Stanley Europe SE

12 January 2026

FORM 38.5(b)(EPT/NON-RI)

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE

UNDER RULE 38.5(b) AND RULE 38.6 OF THE IRISH TAKEOVER

PANEL ACT, 1997, TAKEOVER RULES, 2022 BY A CONNECTED

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED

INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1.             KEY INFORMATION

(a)   Name of exempt principal trader:	Morgan Stanley Europe SE
(b)   Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree	Avadel Pharmaceuticals plc
(c)   Name of the party to the offer with which exempt principal trader is connected: (Note 1)	Avadel Pharmaceuticals plc
(d)   Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure	09 January 2026
(e)   In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2)

Class of relevant security: (Note 3)	0.01 ordinary shares
	Interests		Short positions
Number	%	Number	%
(1)   Relevant securities owned and/or controlled:	0	0.00	0	0.00
(2)   Cash-settled derivatives:	0	0.00	0	0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell:	0	0.00	0	0.00
Total:	0	0.00	0	0.00

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant security	Purchases/ sales	Total number of securities	Highest price per unit paid/ received	Lowest  price per unit paid/ received
0.01 ordinary shares	PURCHASES	4,000	21.5100 USD	21.5100 USD
0.01 ordinary shares	SALES	4,000	21.5100 USD	21.5100 USD

(b)           Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities (Note 5)	Price per unit (Note 6)
N/A	N/A	N/A	N/A	N/A

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 5)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit
N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

(ii)           Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 6)
N/A	N/A	N/A	N/A	N/A

(d)           Other dealings (including transactions in respect of new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion, exercise	Details	Price per unit (if applicable) (Note 6)
N/A	N/A	N/A	N/A

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
NONE

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
NONE

(c)           Attachments

Is a Supplemental Form 8 attached?	NO

Date of disclosure:	12 January 2026
Contact name:	Claire Gordon
Telephone number:	+44 141 245-8893

Public disclosures under Rule 38 of the Rules must be made to a Regulatory Information Service.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPBTMLTMTIBMFF